期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 175, 期 7, 页码 994-1003出版社
WILEY
DOI: 10.1111/bph.14146
关键词
-
资金
- Victorian State Government Operational Infrastructure Scheme
- National Health and Medical Research Council [1105741]
- National Health and Medical Research Council of Australia [1105741] Funding Source: NHMRC
The last decade has seen major advances in neuroscience tools allowing us to selectively modulate cellular pathways in freely moving animals. Chemogenetic approaches such as designer receptors exclusively activated by designer drugs (DREADDs) permit the remote control of neuronal function by systemic drug administration. These approaches have dramatically advanced our understanding of the neural control of behaviour. Here, we review the different techniques and genetic approaches available for the restriction of chemogenetic receptors to defined neuronal populations. We highlight the use of a dual virus approach to target specific circuitries and the effectiveness of different routes of administration of designer drugs. Finally, we discuss the potential caveats associated with DREADDs including off-target effects of designer drugs, the effects of chronic chemogenetic receptor activation and the issue of collateral projections associated with DREADD activation and inhibition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据